HESA Committee Meeting
Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.
For an advanced search, use Publication Search tool.
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
Notice of meeting Amended
Standing Committee on Health (HESA)
42nd Parliament, 1st Session
Meeting 119
Tuesday, October 30, 2018, 8:45 a.m. to 10:45 a.m.
8:45 a.m. to 9:00 a.m.
(In Camera)
9:00 a.m. to 10:15 a.m.
(Public)
WitnessesAmended
Liv-A-Little Foundation
Erin Little, President
atypical Hemolytic Uremic Syndrome Canada
Caryn Vowles, Board MemberAmended
MaryJane Vowles, Board Member
10:15 a.m. to 10:45 a.m.
Department of Health
Catherine Parker, Director General, Biologics and Genetic Therapies Directorate, Health Products and Food Branch
Karen Reynolds, Executive Director, Office of Pharmaceuticals Management Strategies
John Patrick Stewart, Director General, Therapeutic Products Directorate
Clerk of the Committee
Marie-Hélène Sauvé (613-995-4108)
2018-10-29 2:53 p.m.